Literature DB >> 15561595

The influence of small bowel motion on both a conventional three-field and intensity modulated radiation therapy (IMRT) for rectal cancer.

Joost J Nuyttens1, John M Robertson, Di Yan, Alvaro Martinez.   

Abstract

PURPOSE: To investigate the reduction of irradiated small bowel volume with intensity modulated radiation therapy (IMRT) planning in rectal cancer and to asses the variability of the irradiated small bowel in the conventional planning as in the IMRT planning (IMPlan) by obtaining weekly CT scans. PATIENTS AND MATERIALS: Twelve patients with rectal cancer had treatment planning CT scans of the pelvis with small bowel contrast obtained for planning and once a week during treatment (65 CT scans total). The scans were registered using the bony structures. The clinical target volume (CTV), small bowel, large bowel and bladder were outlined on each slice. The first CT scan was used for IMPlan and conventional three-field planning (ConPlan), which were then applied to the CT scans obtained during therapy.
RESULTS: The median value among patients of the mean volume over a patient's scan of small bowel irradiated > or =95% was 112 cm3 (standard deviation (SD): 31 cm3) for the ConPlan and 42 cm3 (SD: 17 cm3) for the IMPlan. The median total bladder volume was 148 cm3 (SD: 130 cm3). There was a good correlation between the volume of irradiated small bowel and the bladder volume for IMPlan with <50 cm3 irradiated small bowel and ConPlan with <150 cm3 (p = 0.002).
CONCLUSION: The use of IMRT led to a potentially clinically meaningful reduction in the volume of small bowel irradiated, even when accounting for small bowel motion. A full bladder was of greatest benefit in individuals with the smallest volume of small bowel in the treatment field.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15561595     DOI: 10.1016/j.canrad.2004.08.001

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN: 1278-3218            Impact factor:   1.018


  9 in total

1.  Intensity-modulated radiotherapy with a belly board for rectal cancer.

Authors:  Joo Young Kim; Dae Yong Kim; Tae Hyun Kim; Sung Yong Park; Se Byeong Lee; Kyung Hwan Shin; Hongryull Pyo; Joo-Young Kim; Kwan Ho Cho
Journal:  Int J Colorectal Dis       Date:  2006-06-27       Impact factor: 2.571

2.  Three-dimensional conformal radiotherapy combined with FOLFOX4 chemotherapy for unresectable recurrent rectal cancer.

Authors:  Jian-Bin Hu; Xiao-Nan Sun; Qi-Chu Yang; Jing Xu; Qi Wang; Chao He
Journal:  World J Gastroenterol       Date:  2006-04-28       Impact factor: 5.742

3.  Management of locally advanced primary and recurrent rectal cancer.

Authors:  Johannes H W de Wilt; Maarten Vermaas; Floris T J Ferenschild; Cornelis Verhoef
Journal:  Clin Colon Rectal Surg       Date:  2007-08

4.  Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implications.

Authors:  Leire Arbea; Luis Isaac Ramos; Rafael Martínez-Monge; Marta Moreno; Javier Aristu
Journal:  Radiat Oncol       Date:  2010-02-26       Impact factor: 3.481

5.  Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas.

Authors:  Robert J Myerson; Michael C Garofalo; Issam El Naqa; Ross A Abrams; Aditya Apte; Walter R Bosch; Prajnan Das; Leonard L Gunderson; Theodore S Hong; J J John Kim; Christopher G Willett; Lisa A Kachnic
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-12-29       Impact factor: 7.038

6.  Long-term Oncological and Functional Outcomes of Chemoradiotherapy Followed by Organ-Sparing Transanal Endoscopic Microsurgery for Distal Rectal Cancer: The CARTS Study.

Authors:  Rutger C H Stijns; Eelco J R de Graaf; Cornelis J A Punt; Iris D Nagtegaal; Joost J M E Nuyttens; Esther van Meerten; Pieter J Tanis; Ignace H J T de Hingh; George P van der Schelling; Yair Acherman; Jeroen W A Leijtens; Andreas J A Bremers; Geerard L Beets; Christiaan Hoff; Cornelis Verhoef; Corrie A M Marijnen; Johannes H W de Wilt
Journal:  JAMA Surg       Date:  2019-01-01       Impact factor: 14.766

7.  Neoadjuvant radiochemotherapy in the treatment of fixed and semi-fixed rectal tumors. Analysis of results and prognostic factors.

Authors:  Robson Ferrigno; Paulo Eduardo Ribeiro dos Santos Novaes; Maria Letícia Gobo Silva; Ines Nobuko Nishimoto; Wilson Toshihiko Nakagawa; Benedito Mauro Rossi; Fábio de Oliveira Ferreira; Ademar Lopes
Journal:  Radiat Oncol       Date:  2006-03-28       Impact factor: 3.481

8.  Evaluation of treatment response and tissue necrosis as prognostic indicators following neoadjuvant chemoradiotherapy in rectal cancer patients.

Authors:  Ji-Han Jung; Ho Jung An; Hyung-Jin Kim; Jonghoon Lee; Kang-Moon Lee; Sung Hwan Kim; Hyeon-Min Cho; Byoung Yong Shim
Journal:  Korean J Intern Med       Date:  2015-12-28       Impact factor: 2.884

9.  Evaluation of small bowel motion and feasibility of using the peritoneal space to replace bowel loops for dose constraints during intensity-modulated radiotherapy for rectal cancer.

Authors:  Siyuan Li; Yanping Gong; Yongqiang Yang; Qi Guo; Jianjun Qian; Ye Tian
Journal:  Radiat Oncol       Date:  2020-09-01       Impact factor: 3.481

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.